My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Sep 14,2016

Net profit of Future Enterprises rose 615.37% to Rs 315.48 crore in the quarter ended June 2016 as against Rs 44.10 crore during the previous quarter ended June 2015. Sales declined 67.64% to Rs 921.19 crore in the quarter ended June 2016 as against Rs 2846.84 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales921.192846.84-68
OPM %24.969.91-
PBDT295.07184.1360
PBT142.3249.92185
NP315.4844.10615

Powered by Capital Market - Live News

Sintex Industries leads gainers on BSEs A group
May 26,2017

Sintex Industries jumped 16.67% at Rs 30.10 with the stock extending Thursdays rally on the basis of adjusted price post-demerger of the companys plastics business. The stock topped the gainers in A group. On the BSE, 1.39 crore shares were traded on the counter so far as against the average daily volumes of 57.13 lakh shares in the past two weeks.

Shares of Sintex Industries are trading post-scheme of arrangement today, 26 May 2017 after the stock turned ex-scheme of arrangement yesterday, 25 May 2017, for the demerger of its plastics division.

Jaiprakash Associates surged 10.84% at Rs 12.68. The stock was the second biggest gainer in A group. On the BSE, 1.55 crore shares were traded on the counter so far as against the average daily volumes of 66.3 lakh shares in the past two weeks.

Kaveri Seed Company spurted 8.58% at Rs 568.85. The stock was the third biggest gainer in A group. On the BSE, 1.33 lakh shares were traded on the counter so far as against the average daily volumes of 70,000 shares in the past two weeks.

Dishman Pharmaceuticals and Chemicals rose 7.23% at Rs 287.75. The stock was the fourth biggest gainer in A group. On the BSE, 4.77 lakh shares were traded on the counter so far as against the average daily volumes of 1.68 lakh shares in the past two weeks.

Ashok Leyland gained 6.8% at Rs 91.90. The stock was the fifth biggest gainer in A group. On the BSE, 30.53 lakh shares were traded on the counter so far as against the average daily volumes of 8.83 lakh shares in the past two weeks.

Powered by Capital Market - Live News

Jaiprakash Power Ventures provides update on Bara STP project
May 26,2017

Jaiprakash Power Ventures announced the third unit of 660 MW of Bara Super Critical Thermal Power Project (BSTPP) implemented by Prayagraj Power Generation Company (PPGCL), (a material unlisted subsidiary of the Company) has successfully commenced commercial operation at 0.00 hours on 26 May, 2017. With this, 1980 MW BSTPP of PPGCL stands fully commenced.

Powered by Capital Market - Live News

HDFC Bank allots 3909200 equity shares
May 26,2017

HDFC Bank has has allotted on 26 May 2017, 3909200 equity shares to the employees of the Bank pursuant to exercise of options under its Employees Stock Options Schemes (ESOS).

The paid up share capital of the Bank will accordingly increase from Rs. 5129818234 equity shares of Rs 2/- each to Rs. 5137636634 equity shares of Rs 2/- each.

Powered by Capital Market - Live News

Ujaas Energy secures order for solar PV plant
May 26,2017

Ujaas Energy has received a letter of intent from Arunachal Pradesh Energy Development Agency for design, supply, installation, testing and commissioning of 200 kwp Grid Connected Solar PV Plant at the State Assembly Building, Itanagar, Arunachal Pradesh.

Powered by Capital Market - Live News

Tera Software appoints company secretary
May 26,2017

Tera Software has appointed B.Sowmya as Company Secretary & Compliance Officer of the Company.

Powered by Capital Market - Live News

Atal Pension Yojana (APY) reaches 53 lakhs subscribers base
May 26,2017

The subscribers base under the Atal Pension Yojana (APY) has reached about 53 Lakhs. At present 235 Banks and Department of Post are involved with the implementation of the scheme. Besides the branches of the banks and CBS-enabled offices of India Post, quite a few banks are sourcing subscribers through their internet banking portals in a paperless environment.

The APY Scheme follows the same investment pattern as applicable to the NPS contribution of Central Government employees. During the year 2016-17, it has earned a return of 13.91%.

With a view to empower the APY subscribers, new functionalities have been developed where under a subscriber can view and print the ePRAN card and Statement of Transactions.

Presently males account for 62% of the subscribers and female for about 38%. Most of the subscribers have opted for monthly contribution; about 97.5% of the subscribers are contributing at monthly intervals, about 0.8% at quarterly intervals and about 1.7% at half yearly intervals.

A majority of the subscribers have opted for a monthly pension of Rs. 1000/-. Presently 51.5% subscribers have opted for a monthly pension of Rs.1000/- and 34.5% of the subscribers have opted for a monthly pension of Rs.5000.

Powered by Capital Market - Live News

Cheviot Company fixes record date for dividend
May 26,2017

Cheviot Company has fixed 16 June 2017 as record date for payment of dividend.

Powered by Capital Market - Live News

Indoco Remedies to pay dividend
May 26,2017

Indoco Remedies announced that dividend, if declared will be dispatched on or after 14 August 2017.

Powered by Capital Market - Live News

Lupin extends recent losses
May 26,2017

Meanwhile, the S&P BSE Sensex was up 216.99 points or 0.71% at 30,967.02.

On the BSE, 1.14 lakh shares were traded on the counter so far as against the average daily volumes of 1.48 lakh shares in the past two weeks. The stock hit a high of Rs 1,163.60 and a low of Rs 1,115 so far during the day.

The stock had hit a 52-week high of Rs 1,750 on 29 July 2016 and 52-week low of Rs 1,108 on 25 May 2017.

The large-cap company has equity capital of Rs 90.33 crore. Face value per share is Rs 2.

Shares of Lupin have fallen 8.76% in two trading sessions from its closing of Rs 1,227.65 on 24 May 2017, on reports that a foreign brokerage has downgraded the stock to outperform from buy earlier and has also lowered its target price to Rs 1,350 from Rs 1,760 earlier.

According to reports, the global brokerage stated that Lupin expects a challenging FY 2018 due to competitive/regulatory pressures in the US and Japan. US concerns are on account of continued customer consolidation, incremental competition in top products, and slower-than-expected Gavis ramp-up, it said. The brokerage further added that a few critical FY 2019 launches of the company have been pushed out to FY 2020.

Shares of Lupin had fallen 1.71% to settle at Rs 1,227.65 on 24 May 2017 after the company announced weak Q4 earnings during market hours on that day.

Lupins consolidated net profit fell 49.16% to Rs 380.21 crore on 1.33% growth in total revenue from operations to Rs 4253.30 crore in Q4 March 2017 over Q4 March 2016.

During Q4 March 2017, the company made a provision for liability towards its Australian subsidiary amounting to Rs 155.90 crore in respect of compensation for patent litigation towards its Isabelle generic launch in Australia.

Lupins shares witnessed selling pressure in the run-up to the announcement of its Q4 results. They had fallen 5.01% in two trading sessions to settle at Rs 1,249 on 23 May 2017, from its closing of Rs 1,314.90 on 19 May 2017.

Lupin is a pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Powered by Capital Market - Live News

Dr Reddys gets healthier after USFDA clears plant after audit
May 26,2017

The announcement was made after market hours yesterday, 25 May 2017.

Meanwhile, the S&P BSE Sensex was up 179.53 points, or 0.63% to 30,945.12.

The stock had dropped 11.15% in six sessions to Rs 2,427.30 yesterday, 25 May 2017 from a close of Rs 2,731.95 on 17 May 2017.

On the BSE, 24,482 shares were traded in the counter so far, compared with average daily volumes of 40,962 shares in the past one quarter.

At the days high of Rs 2,548.75 hit in early trade, the stock had jumped 5%. The stock had hit a low of Rs 2,431.15 so far during the day. The stock had hit a 52-week high of Rs 3,689 on 20 July 2016 and a 52-week low of Rs 2,400 yesterday, 25 May 2017.

The stock had underperformed the market over the past one month till 25 May 2017, dropping 8.25% compared with 2.69% rise in the Sensex. The scrip also underperformed the market in past one quarter, declining 16.01% as against Sensexs 6.43% rise.

The large-cap drug major has equity capital of Rs 82.87 crore. Face value per share is Rs 5.

Dr Reddys Laboratories said that the United States Food & Drug Administration (USFDA) completed the audit of its formulations Srikakulum plant (SEZ) unit II, in Andhra Pradesh on 25 May 2017 with zero observations.

Dr Reddys Laboratories consolidated net profit rose 175.4% to Rs 337.60 crore on 5.4% decline in net sales to Rs 3554.20 crore in Q4 March 2017 over Q4 March 2016.

Dr Reddys Laboratories is an integrated global pharmaceutical company.

Powered by Capital Market - Live News

SI Capital & Financial Services to hold board meeting
May 26,2017

SI Capital & Financial Services will hold a meeting of the Board of Directors of the Company on 29 May 2017, to consider, approve and take on record the Audited Financial Results of the company for the quarter and year ended 31st March 2017.

Powered by Capital Market - Live News

SFL International to hold board meeting
May 26,2017

SFL International will hold a meeting of the Board of Directors of the Company on 30 May 2017, to consider, approve and sign the Standalone Audited Financial Results of the Company, for the last quarter and financial ended on 31st day of March, 2017, and others.

Powered by Capital Market - Live News

Shri Krishna Devcon to hold board meeting
May 26,2017

Shri Krishna Devcon will hold a meeting of the Board of Directors of the Company on 30 May 2017, to consider and approve Audited Financial Results for the Quarter and Year ended on 31st March, 2017.

Powered by Capital Market - Live News

Laurel Organics to hold board meeting
May 26,2017

Laurel Organics will hold a meeting of the Board of Directors of the Company on 30 May 2017, to consider and approve standalone audited financial results of the company, and Standalone Financial Results (standalone) of the Company for the quarter and year ended on 31st March 2017.

Powered by Capital Market - Live News

Ashoka Refineries to hold board meeting
May 26,2017

Ashoka Refineries will hold a meeting of the Board of Directors of the Company on 30 May 2017, to consider, approve and sign the Standalone Audited Financial Results of the Company, for the last quarter and financial ended on 31st day of March, 2017, and others.

Powered by Capital Market - Live News